cervical length


Also found in: Dictionary, Thesaurus, Legal, Encyclopedia, Wikipedia.

cervical length

The length between the external os and the functional internal os of the uterine cervix. At term, the average cervical length is 3.5 to 4.0 cm. A length of 2.0 cm or less is associated with an increased risk of preterm labor.
See also: length
References in periodicals archive ?
The complete response letter stated that the effect of treatment with progesterone vaginal gel 8% in reducing the risk of preterm birth in women with a short uterine cervical length at </= 32 6/7 weeks gestation (p=0.
We remain confident in the PREGNANT study results that showed the administration of progesterone vaginal gel 8% is a safe and effective treatment for patients at risk for preterm birth due to short uterine cervical length in the mid-trimester of pregnancy.
All were between 16 and 22 weeks of a singleton gestation and had a cervical length of less than 30 mm on transvaginal ultrasound but no other risk factors for preterm birth.
for "reduction of risk of preterm birth in women with short uterine cervical length regardless of other risk factors in the mid-trimester of pregnancy.
Food and Drug Administration (FDA) for PROCHIEVE (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.
She explains here why transvaginal ultrasound measurement of cervical length in the midtrimester can be a valuable tool for reducing the incidence of preterm birth.
The PREGNANT (PROCHIEVE Extending GestatioN A New Therapy) study was designed to evaluate the efficacy and safety of PROCHIEVE (progesterone gel) to reduce the risk of preterm birth in women with a short cervical length as measured by transvaginal ultrasound between 19 and <24 weeks of gestation.
In early April, 2011, Ultrasound and Obstetrics and Gynecology published data from a pivotal Phase III clinical trial of PROCHIEVE([R]) (progesterone gel) to reduce the risk of preterm birth in women with a cervical length between 10 and 20 mm as measured by transvaginal ultrasound at mid-pregnancy.
Transvaginal ultrasound, in the meantime, has been widely recognized as a relatively safe, easy-to-perform, sensitive, and reproducible method for detecting shortened cervical length.
NYSE:WPI) reported in December 2010 that in this pivotal Phase III clinical trial, the administration of PROCHIEVE was associated with a statistically significant reduction in the rate of preterm birth in women with a short cervical length at less than or equal to 32 6/7 weeks gestation, the primary endpoint of the study, compared to placebo gel.
Economy recommends a first-trimester ultrasound for dating, sequential cervical length measurements beginning at 16 weeks, serious consideration of cerclage placement if the cervix shortens, and ultrasound for fetal growth surveillance.
NYSE: WPI) today announced positive top-line results from the PREGNANT Study, a large, global Phase III clinical trial evaluating PROCHIEVE 8% vaginal progesterone gel to reduce the risk of preterm birth in women with a short cervical length as measured by transvaginal ultrasound at mid-pregnancy.

Full browser ?